Levaquin and Vascepa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Levaquin (levofloxacin) and Vascepa (icosapent ethyl). Common drug interactions include bronchitis among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Levaquin and Vascepa. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Levaquin?
Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.
What is Vascepa?
Vascepa has active ingredients of icosapent ethyl. It is often used in high blood cholesterol. eHealthMe is studying from 5,894 Vascepa users. Check the latest studies of Vascepa.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
29 people who take Levaquin and Vascepa together, and have interactions are studied.

What are the common drug interactions of Levaquin and Vascepa, by gender? *:
female:
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Arthralgia (joint pain)
- Bronchitis viral (inflammation of the mucous membrane in the bronchial tubes due to infection with streptococcus pneumoniae)
- Cellulitis (infection under the skin)
- Chronic kidney disease
- Contusion (a type of hematoma of tissue in which capillaries)
- Cough
- Dyspnoea (difficult or laboured respiration)
- Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
- Fatigue (feeling of tiredness)
male:
- Chronic kidney disease
- Fatigue (feeling of tiredness)
- Cellulitis of male external genital organ (infection of male genitals soft tissue)
- Diarrhoea
- Ear discomfort
- Ear infection
- Gait disturbance
- Gastric disorder (disease of stomach)
- Hyperkalaemia (damage to or disease of the kidney)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
What are the common drug interactions of Levaquin and Vascepa, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Abscess limb (limb infection)
- Cellulitis of male external genital organ (infection of male genitals soft tissue)
- Chronic kidney disease
- Hyperkalaemia (damage to or disease of the kidney)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Orchitis (inflammation of the testes)
- Scrotal abscess (pus in scrotum)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Urinary tract infection
30-39:
n/a
40-49:
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Chronic kidney disease
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Influenza
- Renal injury (kidney injury)
50-59:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Arthralgia (joint pain)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Bronchitis viral (inflammation of the mucous membrane in the bronchial tubes due to infection with streptococcus pneumoniae)
- Cellulitis (infection under the skin)
- Contusion (a type of hematoma of tissue in which capillaries)
- Cough
- Dyspnoea (difficult or laboured respiration)
- Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
60+:
- Fatigue (feeling of tiredness)
- Hypoaesthesia (reduced sense of touch or sensation)
- Gait disturbance
- Gastric disorder (disease of stomach)
- Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
- Muscle strain (an injury to a muscle in which the muscle fibres tear)
- Pain in extremity
- Platelet count decreased
- Restless legs syndrome (a powerful urge to move your legs)
- Rash
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 9 people, 31.03%
- Pain: 8 people, 27.59%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 27.59%
- High Blood Pressure: 6 people, 20.69%
- Infection: 6 people, 20.69%
- Type 2 Diabetes: 5 people, 17.24%
- Hypersensitivity: 4 people, 13.79%
- Stress And Anxiety: 4 people, 13.79%
- Depression: 4 people, 13.79%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 10.34%
* Approximation only. Some reports may have incomplete information.
Do you take Levaquin and Vascepa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Levaquin and Vascepa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Levaquin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vascepa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Levaquin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vascepa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levofloxacin and icosapent ethyl (the active ingredients of Levaquin and Vascepa, respectively), and Levaquin and Vascepa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Cellcept and Lipitor - a second ago
- Could Tigecycline cause Hypotension? - a second ago
- Rocephin and Wound - Cut Or Puncture for Women aged 50-59 - 3 seconds ago
- Rocephin and Open Wound for Women aged 50-59 - 3 seconds ago
- Rocephin and Laceration for Women aged 50-59 - 4 seconds ago
- Rocephin and Cuts And Puncture Wounds for Women aged 50-59 - 4 seconds ago
- Geodon and Over Weight for Men aged 30-39 - 15 seconds ago
- Geodon and Saturated Fat for Men aged 30-39 - 15 seconds ago
- Geodon and Polyunsaturated Fat for Men aged 30-39 - 15 seconds ago
- Sodium Bicarbonate and Leuprolide Acetate drug interactions for men aged 60+ - 15 seconds ago